Sign In
Buy EDTXF
$0.96
+0 (+0%)
At Close: Jun 22, 2026
Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders
04:18pm, Tuesday, 09'th Jun 2026
TORONTO, June 09, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,
Spectral Medical Inc. (EDT:CA) Shareholder/Analyst Call Transcript
04:38pm, Monday, 08'th Jun 2026
Spectral Medical Inc. (EDT:CA) Shareholder/Analyst Call Transcript
Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral's Tigris Trial
07:00am, Thursday, 04'th Jun 2026
100% follow-up achieved for all 157 patients enrolled in the Tigris trial Mortality at 12 months was 52.8% with PMX vs. 66.7% with standard of care alone (absolute risk reduction of 13.9%; number need
Spectral Medical Announces PMA Submission to U.S. FDA for PMX
07:00am, Friday, 29'th May 2026
TORONTO, May 29, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic s
Spectral Medical Announces First Quarter 2026 Financial Results and Provides Corporate Update
07:30am, Friday, 08'th May 2026
TORONTO, May 08, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic s
Spectral Medical Inc. Announces Participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference
07:30am, Wednesday, 01'st Apr 2026
Toronto, Ontario--(Newsfile Corp. - April 1, 2026) - Spectral Medical Inc. (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, will be participating
Spectral Medical Announces Fourth Quarter and Fiscal 2025 Results and Provides Corporate Update
07:30am, Thursday, 26'th Mar 2026
TORONTO, March 26, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic
TORONTO and DEERFIELD, Ill., March 24, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic
Spectral Medical Provides Update on PMA Submission Timing for PMX-20R
07:30am, Thursday, 26'th Feb 2026
TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic
Spectral Medical Inc. (EDT:CA) Discusses Year-End Update: FDA Filing Timeline, Tigris Trial Results, and Commercialization Readiness Transcript
Reviewing SiBone (NASDAQ:SIBN) & Spectral Diagnostics (OTCMKTS:EDTXF)
03:58am, Saturday, 15'th Nov 2025
Spectral Diagnostics (OTCMKTS:EDTXF - Get Free Report) and SiBone (NASDAQ: SIBN - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two co
Spectral Medical Inc. Files Base Shelf Prospectus and Revised AIF
11:22am, Monday, 29'th Sep 2025
TORONTO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septi
Spectral Medical Announces Publication of EDEN Observational Study
07:30am, Tuesday, 16'th Sep 2025
New Study Strengthens Rationale for Spectral's PMX Therapy by Defining Endotoxic Septic Shock (ESS) as the Highest-Risk Patient Group New Study Strengthens Rationale for Spectral's PMX Therapy by Defi
Spectral Medical Sponsors Unite for Sepsis Symposium, Chicago September 8 – 9, 2025
08:00am, Monday, 08'th Sep 2025
TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic
Spectral Medical Receives US$3 Million From Vantive
07:30am, Monday, 25'th Aug 2025
TORONTO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic
